... a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with ...
https://www.google.com/url?rct=j&sa=t&url=https://www.prnewswire.com/news-releases/poseida-therapeutics-appoints-cynthia-collins-to-board-of-directors-301340551.html&ct=ga&cd=CAIyGjg0YzkwMzEwZTQwYzQxNjA6Y29tOmVuOlVT&usg=AFQjCNElB2DnZxlik5zPHmOcAk7S7Rl-uw
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.